From: Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera
Protein | Sample A | Sample B | Sample C | Sample D | PT25 |
---|---|---|---|---|---|
I-309 (CCL1) | −81.7% | −94.3% | −60.9% | −49.9% | −70.3% |
IGFBP-1 | −82.9% | −72.4% | −57.2% | −55.9% | −54.8% |
TIMP-1 | 159.9% | 44.3% | 299.6% | 226.2% | 141.1% |
NAP-2 | 95.6% | 113.4% | 142.7% | 205.1% | 190.1% |